Brief: Piramal Pharma Limited Announces Consolidated Results For Q2 And H1 FY2024
Oct 28 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* Q2 FY24 REVENUE FROM OPERATION INR 1,911 CRORES, UP 11%
* LIMITED ANNOUNCES CONSOLIDATED RESULTS FOR Q2 AND H1
FY2024
Source text for Eikon: ID:nCNW7b99Ra
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington